Researchers have uncovered critical insights into vitreoretinal lymphoma, a rare and aggressive cancer that can affect the vision and be linked to lymphoma in the brain or other parts of the body.

Using the largest international registry of its kind, researchers at Flinders University, supported by Flinders Foundation, are re-shaping how this disease is understood.

As lead researcher Professor Justine Smith explains, the registry is helping to “address major gaps” in knowledge and offers an “unprecedented opportunity” to improve diagnosis and care.

Why this matters

Earlier diagnosis can:

• Help preserve vision
• Enable faster, life-saving treatment
• Improve outcomes for patients facing an aggressive disease

By analysing the way this cancer first affects patients at scale, clinicians can be better equipped to recognise the disease earlier and act faster.

For rare cancers, lack of data is often a barrier. This research shows the power of global collaboration, turning limited information into life-changing insight.

It’s also a powerful reminder of what donor support makes possible.

With continued investment, we can accelerate progress, improving detection, guiding treatment, and  benefitting patients’ health and living.

This project was co-funded by Flinders Foundation and the Queensland Eye Institute Foundation.